Cannabis stocks rally after DOJ proposal to reclassify marijuana
Public Health,Justice,Marijuana,Marijuana Legalization,Drugs
From the Center
AllSides Media Bias Rating: Center
Cannabis stocks including Tilray (TLRY.O), Curaleaf (CURA.TO), and the AdvisorShares Pure US Cannabis ETF (YOLO.P), rallied on Thursday after the U.S. Department of Justice unveiled a historic proposal to ease restrictions on marijuana.
Under the proposal, cannabis would be reclassified from a so-called Schedule I drug, which are considered highly additive with no medical benefits, to a Schedule III, signifying it has moderate to low potential for physical and psychological dependence.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
News
Under-reported Stories About Gun Regulations, Trump’s War on Drugs, and Canada’s MAID Program Demand a Closer Look
Malayna J. Bizier
August 24th, 2026
Story of the Week
Dr. Fauci Pleads the Fifth
AllSides Staff
July 30th, 2026
Red Blue Translator
FDA (U.S. Food & Drug Administration)
Red Blue Translator
